Thyrocare Technologies shares touched a fresh 52-week high on Wednesday after a stellar 82% YoY growth in Q2FY26 PAT. The company’s Revenue rose 22% to Rs 216.53 crore, while EBITDA expanded 48–49% YoY. Further, the Thyrocare Technologies board also announced a 2:1 bonus.